Scott MacKay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Scott MacKay has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- David Scott Wishart
Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada
5 shared publications - Kovur Prashanthi
Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada
3 shared publications - Upasana Singh
Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada
3 shared publications - Claudia Torres-Calzada
Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada
2 shared publications - James Cook
Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada
2 shared publications - Jie Chen
Department of Electrical and Computer Engineering, University of Alberta, Edmonton, AB, Canada.
2 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by MDPI AG in Engineering Proceedings
- Vol. 163 (1) , 24
A Portable RGB Color-Sensor Platform for On-Farm Prediction of Sheep Pregnancy and Litter Size
Early detection of sheep pregnancy and litter size (PLS) is crucial for the efficient management of the flock. However, standard ultrasonography for these purposes is not cost-effective for flock testing and requires trained and experienced operators. We have developed a simple handheld, real-time RGB color-sensor system that can measure six PLS candidate biomarkers, namely L-carnitine, glucose, lactate, creatinine, urea, and pyruvate using six in-house colorimetric assays, and a companion tablet application to report sheep PLS results. A benchtop microplate reader was used to obtain the measurements of the six assays using spiked, pooled sheep serum to produce a set of assay-specific weighted “color numbers” which were then used to calibrate the portable sensor system. To facilitate pregnancy testing in sheep during the coldest months of Canadian winter, we have also developed a custom-made temperature-controlled heating chamber so that the colorimetric assays can be incubated at approximately 21 °C. Here, we report on outdoor, on-device calibration of two chemically distinct assays spanning the concentration ranges represented in the panel. Creatinine, measured using the non-enzymatic alkaline 3,5-dinitrobenzoic acid reaction, increased monotonically over a concentration range of 0–200 µM (linear fit, R2 = 0.9469). Urea, measured using the enzyme-coupled Berthelot reaction, increased rapidly up to about 10 mM before saturating (quadratic fit, R2 = 0.9864). Both assays produced repeatable and concentration-dependent color change under the variable outdoor winter conditions experienced on-farm and therefore, hold great promise for the on-farm colorimetric measurement of metabolites of interest for pregnancy and litter size in sheep.
- 28 October 2026
- Published by MDPI AG in Engineering Proceedings
- Vol. 163 (1) , 24
Open AccessA Portable RGB Color-Sensor Platform for On-Farm Prediction of Sheep Pregnancy and Litter Size
Early detection of sheep pregnancy and litter size (PLS) is crucial for the efficient management of the flock. However, standard ultrasonography for these purposes is not cost-effective for flock testing and requires trained and experienced operators. We have developed a simple handheld, real-time RGB color-sensor system that can measure six PLS candidate biomarkers, namely L-carnitine, glucose, lactate, creatinine, urea, and pyruvate using six in-house colorimetric assays, and a companion tablet application to report sheep PLS results. A benchtop microplate reader was used to obtain the measurements of the six assays using spiked, pooled sheep serum to produce a set of assay-specific weighted “color numbers” which were then used to calibrate the portable sensor system. To facilitate pregnancy testing in sheep during the coldest months of Canadian winter, we have also developed a custom-made temperature-controlled heating chamber so that the colorimetric assays can be incubated at approximately 21 °C. Here, we report on outdoor, on-device calibration of two chemically distinct assays spanning the concentration ranges represented in the panel. Creatinine, measured using the non-enzymatic alkaline 3,5-dinitrobenzoic acid reaction, increased monotonically over a concentration range of 0–200 µM (linear fit, R2 = 0.9469). Urea, measured using the enzyme-coupled Berthelot reaction, increased rapidly up to about 10 mM before saturating (quadratic fit, R2 = 0.9864). Both assays produced repeatable and concentration-dependent color change under the variable outdoor winter conditions experienced on-farm and therefore, hold great promise for the on-farm colorimetric measurement of metabolites of interest for pregnancy and litter size in sheep.
- Open Access
- 2 September 2026
- Published by MDPI AG in Biosensors
- Vol. 16 (9) , 485
A Portable Colorimetric Biosensor Platform for Urinary Colorectal Cancer Biomarker Testing in Low-Resource Settings
Early detection of colorectal cancer (CRC) is challenging in low-resource settings because access to colonoscopy and centralized laboratory testing is limited. Urine-based metabolite biomarkers offer a non-invasive alternative for CRC triage, but translating a laboratory assay into a point-of-care (PoC) system requires standardized fluid handling, operator-independent timing, field-compatible reagents, and quantitative calibration. Here, we present a low-cost, semi-automated PoC platform integrating a validated, sequential, three-metabolite CRC-biomarker assay with robotic fluid handling, a motorized chromatographic module, an optical reader, Bluetooth electronics, and tablet-guided control. The platform measures urinary diacetylspermine and hippuric acid, with creatinine serving as a normalization reference, and reports absolute quantitative concentrations. Automated dilution, tube positioning, timed incubation, controlled column elution, and software-guided transfer reduce operator-dependent variation. Using pooled urine samples spiked at clinically relevant concentrations, the creatinine assay showed a strong quadratic response (0–50 mM, R2 = 0.998), as did the diacetylspermine assay (0–4 μM, R2 = 0.979), while the hippuric acid assay showed a linear response of R2 = 0.989. The RGB sensor tracked the concentration-dependent trend observed with a laboratory microplate reader (R2 = 0.968–0.999). Reagents reformulated as lyophilized or pre-weighed, vacuum-sealed kits withstood accelerated heat and humidity (45 °C/70% RH) testing and international shipping to the pilot site very well. At approximately USD 490 for the complete instrument (including tablet) and roughly USD 7.65 in consumables per screening test, the platform offers a practical, quantitative, and portable route for decentralized CRC screening.
- 2 September 2026
- Published by MDPI AG in Biosensors
- Vol. 16 (9) , 485
Open AccessA Portable Colorimetric Biosensor Platform for Urinary Colorectal Cancer Biomarker Testing in Low-Resource Settings
Early detection of colorectal cancer (CRC) is challenging in low-resource settings because access to colonoscopy and centralized laboratory testing is limited. Urine-based metabolite biomarkers offer a non-invasive alternative for CRC triage, but translating a laboratory assay into a point-of-care (PoC) system requires standardized fluid handling, operator-independent timing, field-compatible reagents, and quantitative calibration. Here, we present a low-cost, semi-automated PoC platform integrating a validated, sequential, three-metabolite CRC-biomarker assay with robotic fluid handling, a motorized chromatographic module, an optical reader, Bluetooth electronics, and tablet-guided control. The platform measures urinary diacetylspermine and hippuric acid, with creatinine serving as a normalization reference, and reports absolute quantitative concentrations. Automated dilution, tube positioning, timed incubation, controlled column elution, and software-guided transfer reduce operator-dependent variation. Using pooled urine samples spiked at clinically relevant concentrations, the creatinine assay showed a strong quadratic response (0–50 mM, R2 = 0.998), as did the diacetylspermine assay (0–4 μM, R2 = 0.979), while the hippuric acid assay showed a linear response of R2 = 0.989. The RGB sensor tracked the concentration-dependent trend observed with a laboratory microplate reader (R2 = 0.968–0.999). Reagents reformulated as lyophilized or pre-weighed, vacuum-sealed kits withstood accelerated heat and humidity (45 °C/70% RH) testing and international shipping to the pilot site very well. At approximately USD 490 for the complete instrument (including tablet) and roughly USD 7.65 in consumables per screening test, the platform offers a practical, quantitative, and portable route for decentralized CRC screening.
- 1 August 2025
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 11 (11) , e2500062
Point-of-Care Urine Metabolomics Test to Diagnose Colorectal Cancers in Low- and Middle-Income Countries: A Pilot Controlled Trial in Southwestern Nigeria
PURPOSE: To test the feasibility of a point-of-care (POC) real-time urine metabolomics test, evaluate its validity in diagnosing colorectal cancer (CRC) among at-risk patients, and assess the willingness of patients in Southwestern Nigeria to use and pay for the test. METHODS: This was a pilot-controlled trial carried out among 72 patients (34 cases and 38 controls) in southwestern Nigeria. The cases were those with histopathological diagnosis of CRC while controls were at-risk adults. The POC biosensor used a disposable chip and can be connected to a smart device using Bluetooth, and reported if the patient's urine contained metabolites consistent with CRC. We assessed validity of the test using sensitivity, specificity, positive predictive value (PPV) and negative predictive values (NPV), and prespecified a specificity of 50% with a goal of ≥80% sensitivity to estimate the potential of the test to half the referrals to colonoscopy. Additionally, we assessed perception toward the test and willingness to uptake the urine test using structured questionnaires. RESULTS: The overall sensitivity, specificity, PPV, and NPV for all respondents were 91.18%, 81.58%, 81.58%, and 91.18% respectively, with an area under the receiver operating characteristic curve of 0.86. With specificity fixed at 50%, the overall sensitivity for all respondents was 94.5%, and all stratifications had sensitivity >90%. Overall, 70 (98.6%) were satisfied with the urine-based CRC screening, and respondents were willing to pay a mean amount of 8,008.20 Naira (about $5.2 US dollars) for the test. CONCLUSION: Our urine metabolite early diagnosis POC test met our predetermined criteria for success and had high acceptance rates among Nigerian patients, supporting a future multi-institutional implementation trial assessing our ability to scale up utilization.
- 1 August 2025
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 11 (11) , e2500062
Point-of-Care Urine Metabolomics Test to Diagnose Colorectal Cancers in Low- and Middle-Income Countries: A Pilot Controlled Trial in Southwestern Nigeria
PURPOSE: To test the feasibility of a point-of-care (POC) real-time urine metabolomics test, evaluate its validity in diagnosing colorectal cancer (CRC) among at-risk patients, and assess the willingness of patients in Southwestern Nigeria to use and pay for the test. METHODS: This was a pilot-controlled trial carried out among 72 patients (34 cases and 38 controls) in southwestern Nigeria. The cases were those with histopathological diagnosis of CRC while controls were at-risk adults. The POC biosensor used a disposable chip and can be connected to a smart device using Bluetooth, and reported if the patient's urine contained metabolites consistent with CRC. We assessed validity of the test using sensitivity, specificity, positive predictive value (PPV) and negative predictive values (NPV), and prespecified a specificity of 50% with a goal of ≥80% sensitivity to estimate the potential of the test to half the referrals to colonoscopy. Additionally, we assessed perception toward the test and willingness to uptake the urine test using structured questionnaires. RESULTS: The overall sensitivity, specificity, PPV, and NPV for all respondents were 91.18%, 81.58%, 81.58%, and 91.18% respectively, with an area under the receiver operating characteristic curve of 0.86. With specificity fixed at 50%, the overall sensitivity for all respondents was 94.5%, and all stratifications had sensitivity >90%. Overall, 70 (98.6%) were satisfied with the urine-based CRC screening, and respondents were willing to pay a mean amount of 8,008.20 Naira (about $5.2 US dollars) for the test. CONCLUSION: Our urine metabolite early diagnosis POC test met our predetermined criteria for success and had high acceptance rates among Nigerian patients, supporting a future multi-institutional implementation trial assessing our ability to scale up utilization.
- Open Access
- 3 May 2024
- Published by MDPI AG in Nanomaterials
- Vol. 14 (9) , 796
Redox-Modified Nanostructured Electrochemical Surfaces for Continuous Glucose Monitoring in Complex Biological Fluids
Continuous glucose monitoring is valuable for people with diabetes but faces limitations due to enzyme–electrode interactions and biofouling from biological samples that reduce sensor sensitivity and the monitoring performance. We created an enzyme-based electrochemical system with a unique nanocomposite coating that incorporates the redox molecule, aminoferrocene (NH2-Fc). This coating enhances stability via electroactivity and reduces nonspecific binding, as demonstrated through cyclic voltammetry. Our approach enables real-time glucose detection via chronoamperometry with a calculated linear range of 0.5 to 20 mM and a 1 mM detection limit. Validated with plasma and saliva, this platform shows promise for robust metabolite detection in clinical and research contexts. This versatile platform can be applied to accurately monitor a wide range of metabolites in various biological matrices, improving patient outcomes.
- 3 May 2024
- Published by MDPI AG in Nanomaterials
- Vol. 14 (9) , 796
Open AccessRedox-Modified Nanostructured Electrochemical Surfaces for Continuous Glucose Monitoring in Complex Biological Fluids
Continuous glucose monitoring is valuable for people with diabetes but faces limitations due to enzyme–electrode interactions and biofouling from biological samples that reduce sensor sensitivity and the monitoring performance. We created an enzyme-based electrochemical system with a unique nanocomposite coating that incorporates the redox molecule, aminoferrocene (NH2-Fc). This coating enhances stability via electroactivity and reduces nonspecific binding, as demonstrated through cyclic voltammetry. Our approach enables real-time glucose detection via chronoamperometry with a calculated linear range of 0.5 to 20 mM and a 1 mM detection limit. Validated with plasma and saliva, this platform shows promise for robust metabolite detection in clinical and research contexts. This versatile platform can be applied to accurately monitor a wide range of metabolites in various biological matrices, improving patient outcomes.
- Open Access
Using Impedance Measurements to Characterize Surface Modified with Gold Nanoparticles
With the increased practice of preventative healthcare to help reduce costs worldwide, sensor technology improvement is vital to patient care. Point-of-care (POC) diagnostics can reduce time and lower labor in testing, and can effectively avoid transporting costs because of portable designs. Label-free detection allows for greater versatility in the detection of biological molecules. Here, we describe the use of an impedance-based POC biosensor that can detect changes in the surface modification of a micro-fabricated chip using impedance spectroscopy. Gold nanoparticles (GNPs) have been employed to evaluate the sensing ability of our new chip using impedance measurements. Furthermore, we used impedance measurements to monitor surface functionalization progress on the sensor’s interdigitated electrodes (IDEs). Electrodes made from aluminum and gold were employed and the results were analyzed to compare the impact of electrode material. GNPs coated with mercaptoundecanoic acid were also used as a model of biomolecules to greatly enhance chemical affinity to the silicon substrate. The portable sensor can be used as an alternative technology to ELISA (enzyme-linked immunosorbent assays) and polymerase chain reaction (PCR)-based techniques. This system has advantages over PCR and ELISA both in the amount of time required for testing and the ease of use of our sensor. With other techniques, larger, expensive equipment must be utilized in a lab environment, and procedures have to be carried out by trained professionals. The simplicity of our sensor system can lead to an automated and portable sensing system.
Open AccessUsing Impedance Measurements to Characterize Surface Modified with Gold Nanoparticles
With the increased practice of preventative healthcare to help reduce costs worldwide, sensor technology improvement is vital to patient care. Point-of-care (POC) diagnostics can reduce time and lower labor in testing, and can effectively avoid transporting costs because of portable designs. Label-free detection allows for greater versatility in the detection of biological molecules. Here, we describe the use of an impedance-based POC biosensor that can detect changes in the surface modification of a micro-fabricated chip using impedance spectroscopy. Gold nanoparticles (GNPs) have been employed to evaluate the sensing ability of our new chip using impedance measurements. Furthermore, we used impedance measurements to monitor surface functionalization progress on the sensor’s interdigitated electrodes (IDEs). Electrodes made from aluminum and gold were employed and the results were analyzed to compare the impact of electrode material. GNPs coated with mercaptoundecanoic acid were also used as a model of biomolecules to greatly enhance chemical affinity to the silicon substrate. The portable sensor can be used as an alternative technology to ELISA (enzyme-linked immunosorbent assays) and polymerase chain reaction (PCR)-based techniques. This system has advantages over PCR and ELISA both in the amount of time required for testing and the ease of use of our sensor. With other techniques, larger, expensive equipment must be utilized in a lab environment, and procedures have to be carried out by trained professionals. The simplicity of our sensor system can lead to an automated and portable sensing system.
- Open Access
Simulations of Interdigitated Electrode Interactions with Gold Nanoparticles for Impedance-Based Biosensing Applications
In this paper, we describe a point-of-care biosensor design. The uniqueness of our design is in its capability for detecting a wide variety of target biomolecules and the simplicity of nanoparticle enhanced electrical detection. The electrical properties of interdigitated electrodes (IDEs) and the mechanism for gold nanoparticle-enhanced impedance-based biosensor systems based on these electrodes are simulated using COMSOL Multiphysics software. Understanding these properties and how they can be affected is vital in designing effective biosensor devices. Simulations were used to show electrical screening develop over time for IDEs in a salt solution, as well as the electric field between individual digits of electrodes. Using these simulations, it was observed that gold nanoparticles bound closely to IDEs can lower the electric field magnitude between the digits of the electrode. The simulations are also shown to be a useful design tool in optimizing sensor function. Various different conditions, such as electrode dimensions and background ion concentrations, are shown to have a significant impact on the simulations.
Open AccessSimulations of Interdigitated Electrode Interactions with Gold Nanoparticles for Impedance-Based Biosensing Applications
In this paper, we describe a point-of-care biosensor design. The uniqueness of our design is in its capability for detecting a wide variety of target biomolecules and the simplicity of nanoparticle enhanced electrical detection. The electrical properties of interdigitated electrodes (IDEs) and the mechanism for gold nanoparticle-enhanced impedance-based biosensor systems based on these electrodes are simulated using COMSOL Multiphysics software. Understanding these properties and how they can be affected is vital in designing effective biosensor devices. Simulations were used to show electrical screening develop over time for IDEs in a salt solution, as well as the electric field between individual digits of electrodes. Using these simulations, it was observed that gold nanoparticles bound closely to IDEs can lower the electric field magnitude between the digits of the electrode. The simulations are also shown to be a useful design tool in optimizing sensor function. Various different conditions, such as electrode dimensions and background ion concentrations, are shown to have a significant impact on the simulations.